Bruce L. Downey

Bruce L. Downey became a Director at Cardinal Health in 2009. Mr. Downey has also been on the board of directors for C4 Therapeutics since 2015 and an Advisory Partner at NewSprings Health Capital II since 2009. From 2018 to 2020, Mr. Downey was a Director at Melinta Therapeutics and a Director at Momenta Pharmaceuticals from 2009 to 2020. From 1994 to 2008, Mr. Downey served as the Chairman and CEO of Barr Pharmaceuticals, Inc. Mr. Downey has also practiced law privately within his own firm and within multiple roles within the Department of Justice.